课题基金 / 基金详情

A radical new paradigm for heme degradation in enteric pathogens

A radical new paradigm for heme degradation in enteric pathogens
肠道病原体血红素降解的全新范例
批准号:
9906908
负责人:
WILLIAM N LANZILOTTA
金额:
$30.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-15 至 2023-04-30

项目摘要

项目成果

WILLIAM N LANZILOTTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY For pathogens, the ability to acquire iron is critical and one of the best-understood indicators of virulence. Numerous pathogenic organisms take advantage of the abundance of heme in the host cell and the human diet as a source of essential iron. Until recently however, all of the known heme degrading enzymes required molecular oxygen for function. In this project, we will investigate the mechanism of anaerobic heme degradation in enterohemorrhagic E. coli (EHEC), a facultative anaerobic pathogen (e.g. O157:H7, which causes bloody diarrhea, hemolytic uremic syndrome, kidney failure and death). We recently found that the ChuW enzyme from EHEC catabolyzes heme and liberates iron under strictly anaerobic conditions. This newly identified anaerobic heme degradation enzyme is part of an important module of heme utilization proteins (ChuW, X, Y in E. coli) that is also found in other aggressive pathogens such as Vibrio cholerae. Identification and characterization of this new pathway in enteric pathogens provides an unexplored opportunity for developing novel antimicrobial compounds. In addition, the enzyme at the heart of this investigation (ChuW) is a radical SAM methyltransferase (RSMT); it utilizes a [4Fe-4S] cluster to generate a powerful radical species that facilitates the liberation of iron from heme through a methyl transfer reaction and chemical rearrangement of the porphyrin. ChuW is capable of methylating an otherwise unreactive sp2- hybridized carbon atom. Furthermore, ChuW is a member of the class C RSMTs, which are poorly understood but have already been shown to catalyze key reactions in the biosynthesis of novel compounds with antitumor and antibiotic properties. This work will provide new insight into this important class of RSMTs and how they control highly reactive radicals to facilitate specific chemical conversions in the biosynthesis of compounds including anti-microbial and anti-tumor agents. Using a multifaceted approach that combines traditional enzyme kinetics, rigorous spectroscopic techniques, and modern structural biology tools, we will characterize the mechanism of anaerobic heme degradation by ChuW, the properties of the anaerobic catabolites, and the interplay of two additional proteins with ChuW in the anaerobic degradation of heme as well as the transport and further reduction of the catabolites. The latter is important given recent work showing that heme degradation products play a vital role in regulation of heme flux and iron homeostasis in other aggressive pathogens. Our specific aims are to determine whether: ChuW catalyzes the liberation of iron from heme via a radical SAM methyltransferase mechanism (using 5'-dAdo• and resulting in formation of “anaerobilin”) (Aim 1); ChuX facilitates the chelation of the iron atom and delivery of “anaerobilin” to ChuY (Aim 3); and ChuY catalyzes the NADPH-dependent reduction of anaerobilin to “anaerorubin” (Aim 2). Our long term goal is to provide the necessary mechanistic insight to selectivity target the anaerobic heme degradation pathway, which appears to be specifically associated with a select set of aggressive, opportunistic, and pathogenic bacteria.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jinorgbio.2021.111636
发表时间: 2022-01
期刊: Journal of inorganic biochemistry
影响因子: 3.9
作者: [Brimberry MA, Mathew L, Lanzilotta W]
通讯作者: Lanzilotta W
A radical new paradigm for heme degradation in enteric pathogens
  • 批准号:
    9929890
  • 项目类别:
  • 资助金额:
    $3.45万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM N LANZILOTTA
  • 依托单位:
A radical new paradigm for heme degradation in enteric pathogens
  • 批准号:
    9366043
  • 项目类别:
  • 资助金额:
    $32.71万
  • 财政年份:
    2017
  • 负责人:
    WILLIAM N LANZILOTTA
  • 依托单位:
CRYSTAL STRUCTURE OF REVERSE RUBRERYTHRIN IN THE OXIDIZED AND REDUCED FORMS
  • 批准号:
    7181046
  • 项目类别:
  • 资助金额:
    $1.03万
  • 财政年份:
    2005
  • 负责人:
    WILLIAM N LANZILOTTA
  • 依托单位:
HIGH RESOLUTION AND PH PROFILE FOR TAURINE ALPHA KETO
  • 批准号:
    6977226
  • 项目类别:
  • 资助金额:
    $0.64万
  • 财政年份:
    2004
  • 负责人:
    WILLIAM N LANZILOTTA
  • 依托单位:
海外基金